title: Is there clear evidence that middle molecule removal is important in renal replacement therapies?
authors.affiliation: Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands. nc.vdweerd@vumc.nl
authors.forename: Neelke C
authors.initials: NC
authors.lastname: van der Weerd
authors.forename: Muriel P C
authors.initials: MP
authors.lastname: Grooteman
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Blankestijn
authors.forename: Marinus A
authors.initials: MA
authors.lastname: van den Dorpel
authors.forename: E L
authors.initials: EL
authors.lastname: Penne
authors.forename: Piet M
authors.initials: PM
authors.lastname: ter Wee
authors.forename: Menso J
authors.initials: MJ
authors.lastname: Nubé
mesh_terms: D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism* / Q000628:therapy*; D008970:Molecular Weight; D017582:Renal Replacement Therapy